Tumor‐associated immunoglobulins. enhancement of syngeneic tumors by igg2‐containing tumor eluates

Maya Ran*, Isaac P. Witz

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


The present study was intended to establish whether IgG2‐containing eluates, dissociated from carcinogen‐induced tumors by a low pH buffer, have tumor‐enhancing properties. Threshold amounts of cells from mouse tumor lines originally induced by benzo (a)‐pyrene or by methylcholanthrene were mixed and incubated, prior to inoculation, with IgG2‐containing eluates, originating either from the corresponding tumors (autologous eluates) or from other syngeneic tumors (isologous eluates). Tumor cells incubated and injected together with autologous eluates gave in some experiments a higher yield of tumors in syngeneic mice than did cells not subjected to this treatment. Some isologous eluates originating from several primary tumors or from syngeneic tumors belonging to a different line from the one tested, were also capable of enhancing tumor growth.

Original languageEnglish
Pages (from-to)242-247
Number of pages6
JournalInternational Journal of Cancer
Issue number1
StatePublished - 15 Jan 1972


Dive into the research topics of 'Tumor‐associated immunoglobulins. enhancement of syngeneic tumors by igg2‐containing tumor eluates'. Together they form a unique fingerprint.

Cite this